FI964653A0 - 1-(difenyylimetyyli)-4-(3-(2-fenyyli-1,3-dioksolan-2-yyli)propyyli)piperatsiinin A- ja B-polymorfit - Google Patents

1-(difenyylimetyyli)-4-(3-(2-fenyyli-1,3-dioksolan-2-yyli)propyyli)piperatsiinin A- ja B-polymorfit

Info

Publication number
FI964653A0
FI964653A0 FI964653A FI964653A FI964653A0 FI 964653 A0 FI964653 A0 FI 964653A0 FI 964653 A FI964653 A FI 964653A FI 964653 A FI964653 A FI 964653A FI 964653 A0 FI964653 A0 FI 964653A0
Authority
FI
Finland
Prior art keywords
diphenylmethyl
dioxolan
polymorphs
phenyl
piperazine
Prior art date
Application number
FI964653A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964653A (fi
Inventor
Ambros Rafael Foguet
Burniol Lluis Anglada
Hernandez Jose A Ortiz
Munoz Aurelio Sacristan
Barenys Josep Maria Castello
Carreno Manuel Mauricio Raga
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of FI964653A0 publication Critical patent/FI964653A0/fi
Publication of FI964653A publication Critical patent/FI964653A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI964653A 1995-03-28 1996-11-21 1-(difenyylimetyyli)-4-(3-(2-fenyyli-1,3-dioksolan-2-yyli)propyyli)piperatsiinin A- ja B-polymorfit FI964653A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES1995/000033 WO1996030366A1 (es) 1995-03-28 1995-03-28 Polimorfos a y b de 1-(difenilmetil)-4-[3-(2-fenil-1,3-dioxolan-2-il)propil]piperazina

Publications (2)

Publication Number Publication Date
FI964653A0 true FI964653A0 (fi) 1996-11-21
FI964653A FI964653A (fi) 1996-11-21

Family

ID=8289110

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964653A FI964653A (fi) 1995-03-28 1996-11-21 1-(difenyylimetyyli)-4-(3-(2-fenyyli-1,3-dioksolan-2-yyli)propyyli)piperatsiinin A- ja B-polymorfit

Country Status (14)

Country Link
US (1) US5852021A (de)
EP (1) EP0785196B1 (de)
JP (1) JPH10501555A (de)
KR (1) KR970703337A (de)
AT (1) ATE194004T1 (de)
AU (1) AU690974B2 (de)
DE (1) DE69517593T2 (de)
DK (1) DK0785196T3 (de)
ES (1) ES2149353T3 (de)
FI (1) FI964653A (de)
GR (1) GR3034463T3 (de)
NO (1) NO965050L (de)
PT (1) PT785196E (de)
WO (1) WO1996030366A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8308553A1 (es) * 1982-06-17 1983-09-01 Ferrer Int "procedimiento de obtencion de nuevos derivados de piperazina".

Also Published As

Publication number Publication date
AU2074095A (en) 1996-10-16
GR3034463T3 (en) 2000-12-29
WO1996030366A1 (es) 1996-10-03
EP0785196B1 (de) 2000-06-21
EP0785196A1 (de) 1997-07-23
ES2149353T3 (es) 2000-11-01
DE69517593D1 (de) 2000-07-27
JPH10501555A (ja) 1998-02-10
NO965050D0 (no) 1996-11-27
DK0785196T3 (da) 2000-10-16
FI964653A (fi) 1996-11-21
AU690974B2 (en) 1998-05-07
ATE194004T1 (de) 2000-07-15
NO965050L (no) 1996-11-27
PT785196E (pt) 2000-12-29
DE69517593T2 (de) 2001-03-08
US5852021A (en) 1998-12-22
KR970703337A (ko) 1997-07-03

Similar Documents

Publication Publication Date Title
BR9611436A (pt) D-tartarato de (-)-cis-6(s)-fenil-5(r)-[4-(2-pirrolidin-1-iletóxi) fenil]-5,6,7,8,-tetra-hidronaftalen-2-ol
DE69606196D1 (de) 1-(1,2-disubstituierte piperidinyl)-4-substituierte piperazin derivate
TR199600438A2 (tr) Piperazin türevleri.
NO912348L (no) Fremgangsmaate for fremstilling av papir.
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
HK1016177A1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
NO913405L (no) Maskin for fremstilling av ledning.
DK686088D0 (da) 2-phenyl-3-(piperazin-1-yl)-1-(1h-1,2,4-triazol-1-yl) propan-2-ol-forbindelser
FI862206A (fi) Anordning foer fasthaollning, akustisk taetning och vibrationsisolering av en elektroakustisk omvandlare.
FI964653A0 (fi) 1-(difenyylimetyyli)-4-(3-(2-fenyyli-1,3-dioksolan-2-yyli)propyyli)piperatsiinin A- ja B-polymorfit
FI852423A0 (fi) 1-(bis-(4-fluorofenyl)-metyl)- 4-(3-fenyl-2-propenyl)-hexahydro-1h-1,4-diazepin med kalciumantagonistverkan, dess framstaellning och kompositioner innehaollande densamma.
FI914906A (fi) 1-(3,4-dihydro-2-oxo-1h-kinolin-6-yl) -2-(4-(2-fenyletyl) piperidin-1-yl)etanol och -etanon, deras framstaellning och anvaendning inom terapi.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
FI850641L (fi) Anordning foer maetning av den vaermemaengd som av ett vaermeelement avges till ett rum och foer samtidig reglering av floedet av den genom vaermeelementet stroemmande vaermebaeraren.
YU83181A (en) Process for obtaining 2-(3-(4-(3-chloro-4-fluoro-phenyl)-1-piperazinyl)-propyl)-1,2,4-triazolo(4/3-a)-pyridine-3(2h)-ones
ES538242A0 (es) Un procedimiento de preparar un derivado de 4,5-dihidro-6-(2-(4-(1h-imidazol-1-il)-fenil)-alquilenil o alquilen-3(2h)-piridazinona.
FI923723A0 (fi) 4-(4-(4-4-hydroxifenyl)-1 -piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat.
FI863910A (fi) Foerfarande foer framstaellning av substituerade 3-(4-fenyl-1-piperazinyl)-alkylkinazolin-2,4-(1h,3h) dioner och nya mellanprodukter.
ES493888A0 (es) Un metodo de preparar derivados de piperidina
ZA81688B (en) 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
DE69735341D1 (de) Benzo(b)thiophenderivate, Zwischenprodukte, Zubereitungen und Verfahren
FI892369A0 (fi) Foer anvaendning inom kardiovaskulaer kirurgi avsett implantat av titan och foerfarande foer framstaellning av detsamma.
UA8184A1 (uk) 1-(гідразинокарбоніл)алкил-1, 2-дигідро-3н-1, 4-бенздиазипін-2-они, що мають транквілізуючі та протисудорожні властивості
NO872221L (no) Mellomprodukter for fremstilling av ((4-(4-(4-fenyl-1-piperazinyl)fenoksymetyl)-1,3-dioksolan-2-yl)-metyl)-1h-imidazoler og 1h-1,2,4-triazoler og deres fremstilling.